Epidermal growth factor receptor tyrosine-kinase inhibitor treatment resistance in non-small cell lung cancer: biological basis and therapeutic strategies.
about
Role of rebiopsy in relapsed non-small cell lung cancer for directing oncology treatmentsNext-generation EGFR/HER tyrosine kinase inhibitors for the treatment of patients with non-small-cell lung cancer harboring EGFR mutations: a review of the evidenceA bispecific enediyne-energized fusion protein targeting both epidermal growth factor receptor and insulin-like growth factor 1 receptor showing enhanced antitumor efficacy against non-small cell lung cancerIsoliquiritigenin induces apoptosis and inhibits xenograft tumor growth of human lung cancer cells by targeting both wild type and L858R/T790M mutant EGFR.Glycyrrhetinic acid induces G1‑phase cell cycle arrest in human non‑small cell lung cancer cells through endoplasmic reticulum stress pathway.The HSP90 inhibitor ganetespib potentiates the antitumor activity of EGFR tyrosine kinase inhibition in mutant and wild-type non-small cell lung cancer.244-MPT overcomes gefitinib resistance in non-small cell lung cancer cellsTargeted therapies for treatment of non-small cell lung cancer--Recent advances and future perspectives.Genomic landscape of gastric cancer: molecular classification and potential targets.The Frequency of EGFR Mutation in Lung Adenocarcinoma and the Efficacy of Tyrosine Kinase Inhibitor Therapy in a Hungarian Cohort of Patients.Highly sensitive detection of epidermal growth factor receptor in lung cancer cells by aptamer-based target-/probe-mediated cyclic signal amplification.
P2860
Q26852206-BCD63D09-D81C-4948-8B9A-9CF9B0382AB9Q28079320-E5245756-BB00-4338-925A-E7D2927E86B1Q33689021-078ED054-9BE9-46CD-8C8F-9C8727F578A9Q34774462-1F0AB389-2D88-4481-8D5F-89BA870B22A2Q35073336-07CC36B7-BCC4-4F80-A9F4-EE5DD6F441EEQ35689752-326969D3-CD84-4470-8892-1BA65DD79A81Q36688956-AAB427F4-213B-40AA-B294-E516497B3E1AQ38625550-7514ADA7-63E0-486E-8AD0-8C7FC3887C86Q38837669-83AD64FC-F1E4-4D55-80C4-CE915184A702Q39829525-99356C6E-FEFA-43BB-8FBC-380BF5F6ACC9Q47589765-ECE3CD85-1E63-4CE5-8FAD-7A80C9C499CA
P2860
Epidermal growth factor receptor tyrosine-kinase inhibitor treatment resistance in non-small cell lung cancer: biological basis and therapeutic strategies.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Epidermal growth factor recept ...... is and therapeutic strategies.
@en
type
label
Epidermal growth factor recept ...... is and therapeutic strategies.
@en
prefLabel
Epidermal growth factor recept ...... is and therapeutic strategies.
@en
P2093
P2860
P1476
Epidermal growth factor recept ...... is and therapeutic strategies.
@en
P2093
A R de Lobera
G L Vivanco
P2860
P2888
P304
P356
10.1007/S12094-013-1143-9
P577
2013-12-04T00:00:00Z